Showing results (271-280 of 336) with videos related to

Sort By:
Pageof 34
Oncotarget|April 30, 2016
Potential role of exosome-associated microRNA panels and in vivo environment to predict drug resistance for patients with multiple myelomaLi Zhang, Ling Pan, Bing Xiang, et al.
Anti-Cancer Drugs|April 23, 2005
Synergistic anti-tumor effect of recombinant human endostatin adenovirus combined with gemcitabineYang Wu, Li Yang, Bing Hu, et al.
Open Medicine (Warsaw, Poland)|November 26, 2024
Ferroptosis-related prognostic model of mantle cell lymphomaQianwen Gao, Xin Wang, Yue Zhang, et al.
Cell Reports. Medicine|October 9, 2025
A nanobody-based tri-specific NK cell engager targeting CD5 triggers antitumor immunityChen Yang, Ping Wang, Mingjun Yang, et al.
Biochemical Pharmacology|April 14, 2025
LncRNA HCG11 regulates selinexor sensitivity in multiple myelomaYue Zhang, Xin Wang, Hongmei Luo, et al.
Biochemical Pharmacology|March 7, 2025
The mitochondrial protease ClpP is a promising target for multiple myeloma treatmentXiang Liu, Jinlong Gu, Song Liu, et al.
Science Advances|October 8, 2021
Leukemic progenitor cells enable immunosuppression and post-chemotherapy relapse via IL-36-inflammatory monocyte axisHe-Zhou Guo, Zi-Hua Guo, Shan-He Yu, et al.
Thrombosis Research|March 10, 2015
Combination of FVIII and low-dose rFVIIa improves haemostasis in acquired haemophilia A patients: a collaborative controlled studyXiao-Hui Zhang, Xiao-Lu Zhu, Ting Niu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2019
Purinostat Mesylate Is a Uniquely Potent and Selective Inhibitor of HDACs for the Treatment of BCR-ABL-Induced B-Cell Acute Lymphoblastic LeukemiaLinyu Yang, Qiang Qiu, Minghai Tang, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 19, 2022
Daratumumab, Bortezomib, and Dexamethasone versus Bortezomib and Dexamethasone in Chinese Patients With Relapsed or Refractory Multiple Myeloma: Updated Analysis of LEPUSWeijun Fu, Wei Li, Jianda Hu, et al.
Pageof 34